[Federal Register Volume 86, Number 74 (Tuesday, April 20, 2021)]
[Notices]
[Page 20521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08078]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on March 29, 2021, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium 
(``MCDC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, AAG Associates LLC, Pocasset, MA; Arrevus, Inc., Raleigh, 
NC; Chemring Sensors & Electronic Systems, Inc., Charlotte, NC; Federal 
Resources Supply Company, Stevensville, MD; Genovac Antibody Discovery, 
Fargo, ND; Hager Biosciences LLC, Bethlehem, PA; Healion Bio, Inc., 
Ijamsville, MD; Immunome, Inc., Exton, PA; Invenra, Inc., Madison, WI; 
Optoknowledge, Torrance, CA; Sanaria, Inc., Rockville, MD; Tao 
Treasures dba Nanobiofab, Frederick, MD; TFF Pharmaceuticals, Inc., 
Austin, TX; The University of Nebraska at Omaha, Omaha, NE; The 
University of California Los Angeles, Los Angeles, CA and Tiber Creek 
Partners LLC, Oakton, VA have been added as parties to this venture.
    Also, Abiogenix, Inc., Rochester, MI; Blade Therapeutics, Inc., 
South San Francisco, CA; South San Francisco, CA; Bluejay Diagnostics, 
Inc., Acton, MA; Claremont Biosolutions LLC, Upland, CA; Decisive Point 
LLC, Alexandria, VA; Efiia Consulting LLC, Falls Church, VA; Equillium, 
Inc., La Jolla, CA; GenScript USA, Inc.; LDS Technology Consultants, 
Inc., Warwick, PA; Lillian Bay Holdings LLC, Saint Petersburg, FL; 
Massachusetts Eye and Ear Infirmary, Boston, MA; PhaseBio 
Pharmaceuticals, Inc., Malvern, PA; Planet Biotechnology, Inc., 
Hayward, CA; Shift Labs, Inc., Seattle, WA; The University of 
California San Diego, La Jolla, CA; ThermoAnalytics, Inc., Calumet, MI 
and United National Native Council, Payson, AZ have withdrawn as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on January 08, 
2021. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on January 19, 2021 (86 FR 5250).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-08078 Filed 4-19-21; 8:45 am]
BILLING CODE P